| Role |
Name |
Disclosure |
Details |
| Author | Ignazio Stanganelli, MD, Director of Cutaneous Oncology, Niguarda Ca' Granda Hospital; Director, Skin Cancer Unit, Center for Cancer Prevention, Italy | Nothing to disclose | Details | | Coauthor | Maria Antonietta Pizzichetta, MD, Consulting Staff, Division of Preventive Oncology, Centro Di Riferimento Oncologico of Aviano, Italy | Nothing to disclose | Details | | Medical Editor | Harold S Rabinovitz, MD, Clinical Professor, Department of Dermatology, University of Miami School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Managing Editor | Amanda Oakley, MBChB, FRACP, Clinical Director, Clinical Associate Professor, Department of Dermatology, Waikato Hospital, Hamilton, New Zealand | Nothing to disclose | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | AMGEN AMGEN Genentech Centocor Centocor Covance Shire | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Ignazio Stanganelli, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Maria Antonietta Pizzichetta, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Harold S Rabinovitz, Medical Editor |
The contributor discloses no conflict of interest. |
|